Ratings by LifeSci Capital (Patrick Dolezal)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/26/2026 | Neurogene | NGNE | New Coverage | Outperform (N/A) |
18.31 (30.86) |
68.54% | Details | |
| 5/20/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/16/2022 | Larimar Therapeutics | LRMR | Downgrade | Market Perform (Outperform) |
4.01 (3.68) |
-8.23% | Details |
